Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma

NCT03664323 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

BIOLOGICAL: Evaluate the improvement in response from the end of anti-PD-1 monotherapy

Sponsor

Hospices Civils de Lyon